Stories

The text discusses the growing popularity of heated tobacco products like IQOS and their potential health risks. Tobacco companies claim these products are less harmful than cigarettes, but experts warn of health concerns, marketing to youth, and lack of long-term research. Studies show heated tobacco can lead to smoking, emissions may contain harmful chemicals, and dual use may increase health risks. Public health officials urge caution, as these products could encourage more tobacco consumption. Concerns also arise about the marketing tactics targeting young people. Research suggests heated tobacco may not be a safe alternative to smoking. Vigilance is key as these products enter the market.

State-level PMTA registry bills have posed a threat to vaping by potentially banning most products tied to FDA approval. Some states already shut down vape shops, limiting harm reduction options. Despite concerns, Tennessee and North Dakota revised their bills, shifting focus to US-made products. North Dakota abandoned its proposal due to advocacy efforts, emphasizing American-made items. Fear-based policymaking and misinformation still influence decisions, impacting harm reduction progress. The political shift reflects trade interests more than public health. However, the compromised bills in Tennessee and North Dakota preserve access to nicotine alternatives, pending Governor Lee's approval. Challenges persist for over 650,000 adult vapers in these states amidst ongoing regulatory uncertainties.

Governments, WHO, and public interest groups obstruct the shift from deadly combustible cigarettes to safer alternatives like e-cigarettes. The transition, progressing rapidly in countries like Sweden and Japan, offers hope in ending smoking. Despite the reduced harm of new nicotine products, efforts to accelerate the switch face resistance. Influential bodies like WHO and nonprofits like Campaign for Tobacco Free Kids oppose e-cigarettes. Supported by Bloomberg, they hinder progress in low- and middle-income countries by advocating against safer options.

For decades, nicotine has been viewed primarily as a harmful and addictive substance — the main reason people become hooked on cigarettes and other tobacco products. Humans have used tobacco for over 12,000 years, whether by smoking, chewing, or sniffing it. In more recent years, pharmaceutical companies have developed nicotine patches, gums, and lozenges to help people quit smoking — all available without a prescription. However, new research is beginning to challenge this one-sided view. Scientists are now exploring whether nicotine might also offer potential therapeutic benefits. Some studies suggest it could help people suffering from long COVID or Alzheimer’s disease. This emerging perspective could change how we understand and use nicotine in modern medicine.

EU governments are imposing stricter regulations on nicotine pouches, with Spain proposing a 0.99 mg limit, potentially hampering free movement of goods. Sweden challenges this move, citing EU laws. Precedents like the Cassis de Dijon case and the German Beer Purity Law indicate that such restrictions may violate EU trade laws. Spain's proposal lacks scientific basis, leaning towards de facto bans. The arbitrary limit may face legal obstacles based on past rulings, emphasizing EU principles on free trade. The EU must intervene to ensure fair market access and support safer alternatives for smokers in Spain.

Three research firms — Cannabis Public Policy Consulting (New York), Capital Consulting Services (St. Louis), and Whitney Economics (Oregon) — are competing to study Missouri’s cannabis market. The goal is to help the state decide whether to issue more adult-use marijuana business licenses. All firms agree that Missouri’s recreational cannabis market, launched in 2022, has been a success. Experts say the success is largely due to the state issuing only the minimum number of licenses allowed by its constitution.

The CEO of Philip Morris International’s U.S. business claims nicotine is misunderstood and offers cognitive benefits, arguing that regulators should support smoking alternatives. This comes as PMI pushes to end cigarette sales. With Robert F. Kennedy Jr. now leading the Department of Health and Human Services, there may be major changes in tobacco regulation. Meanwhile, PMI's nicotine pouch brand Zyn is seeing rapid growth in the U.S., with shipments in the Americas up nearly 54% in Q1 2025. Smoke-free products now make up 42% of PMI's revenue, compared to 25% a year ago. Although PMI still earns most of its revenue from smokers, that could soon shift due to Zyn’s rising popularity.

Nicotine pouch use doubled among U.S. high school students from 2023 to 2024, with 5.4% reporting usage. This emerging trend raises concerns, mirroring the past rise of flavored e-cigarettes. The FDA's decision to allow marketing of Zyn pouches to adults is controversial, given their popularity among teens. Research shows a demographic pattern favoring white males in rural areas. Both nicotine pouch and e-cigarette use increased in 2024, with more teens engaging in dual use. Long-term health effects are uncertain, but addiction risks persist. Preventative measures and regulation are crucial to address this public health issue. Tracking trends and evaluating policies are essential for targeted prevention strategies.

Consumer groups and vaping advocates in Europe oppose Greece's plan to ban flavoured e-cigarettes, fearing it will harm harm reduction efforts. They argue that flavours help smokers switch to safer options and caution against unintended consequences seen in Denmark. The ban risks driving former smokers back to cigarettes and the black market. Data shows adult vapers prefer flavoured products. Experts recommend science-based regulations that protect public health while supporting harm reduction. In Denmark, a ban on vape flavours unintentionally increased youth use and spurred illegal sales. Critics warn against over-regulation and point to Sweden's harm reduction success. Research confirms flavoured vapes aid smoking cessation. Advocates call for evidence-based policies to safeguard gains in public health.

A study by Karolinska Institutet suggests higher cigarette taxes in low and middle-income countries could reduce child mortality, benefiting the poorest children. The research indicates that implementing WHO's recommended 75% tax could have potentially saved over 280,000 children's lives. The study analyzed data from 94 countries between 2008-2020, showing how increased cigarette taxes can improve child survival across all socioeconomic groups. Lead author Olivia Bannon emphasizes the importance of raising cigarette taxes to protect children's health, particularly in vulnerable populations. The study highlights the need to combat tobacco industry interference to implement effective tobacco control policies globally.